This website is part of the ECDC (European Centre for Disease Prevention and Control) network
European Scientific Conference on Applied Infectious Disease Epidemiology
ESCAIDE 2016 Keynote address: Open data
Prof. Henrik Wegener is the Executive Vice President at Technical University of Denmark (DTU) and an expert on food safety, zoonosis, antimicrobial resistance as well as emerging infectious diseases.
He has served as advisor to national and international authorities & governments, international organizations and private companies, and universities and research foundations, and is presently serving, on several national and international committees and boards on food safety, veterinary public health, and research policy.
Most recently he was appointed Chair of the High Level Group of the EC Scientific Advice Mechanism (SAM).
Conflict of interest Declaration
PLENARY B: Integrating Epidemiological and Genomic Modelling on Communicable Disease Transmission
PLENARY C: Migrant Health
PLENARY D: The needs and roles of the public and private sector in delivering effective immunisation programmes: the Yin and Yang of vaccination
Andrea Rappagliosi joined the Sanofi Pasteur MSD Executive Committee in July 2012 as Vice President Market Access, Health Policy and Medical Affairs.
Born in Rome, Andrea received a law degree from the University of Rome “La Sapienza”. He began his professional career in the Italian Senate. Before joining SPMSD, he worked at Baxter Healthcare, Serono International and GSK in different European and International positions in the market access and policy area.
Plenary speaker: Dr. Lyle Petersen
Lyle R. Petersen, M.D., M.P.H., has served
as the director of the Division of Vector-borne Diseases since 2004.
Petersen began his training at the University of California, San Diego where he
received an undergraduate degree in biology. He then studied medicine at the University of California, San Francisco,
where he was awarded a Regent’s Scholarship. After medical school, Dr. Petersen completed his internship and
residency in internal medicine at Stanford University. He then joined Tulane University’s tropical
medicine research efforts in Cali, Colombia before starting CDC’s Epidemic
Intelligence Service (EIS) applied epidemiology training program in 1985. After his EIS training at the Connecticut
State Health Department, he joined the CDC’s Division of HIV/AIDS where he
worked until 1995.
During that time, he
completed CDC’s Preventive Medicine Residency Program, received an MPH degree
from Emory University, and served in several posts, including the Chief of the
HIV Seroepidemiology Branch. From 1996
to February 2000, Dr. Petersen guided Germany’s efforts in creating a new
national infectious disease epidemiology program at the Robert Koch Institute
in Berlin. From 2000 to 2003, he served
as the Deputy Director for Science of the Division of Vector-borne
Diseases. He is the author of more than
175 scientific publications.
Dr. Petersen has been the recipient of
several scientific awards including the Charles B. Shepard Science Award, the
Alexander D. Langmuir Award, James H. Nakano Citation, and twice the HHS
Secretary’s Award for Distinguished Service. He served on the National Security Staff at the White House, currently
serves on the editorial boards of two medical journals, is a member of the
Faculty of 1000, and is the Incident Manager of the Zika Response at the CDC. Dr. Petersen’s current research focuses on
the epidemiology of arboviral and bacterial vector-borne zoonoses.
Conflict of Interest Declaration
Dr. Rocklöv an Associate
Professor in epidemiology with application to infectious disease. His main
focus is with vector-borne disease, such as dengue and Zika. He has a specific interest in disease dynamics, understanding drivers of spread, and establishing
predictions and forecasting models to inform policy and facilitate timely
Conflict of interest Declaration
Anna has extensive experiences of leading research
focused on HIV and TB epidemiology, health systems and implementation research,
specifically in low-income settings and vulnerable groups. Anna´s research also includes infectious
disease epidemiology related to influenza, as well as innovative m- and e-
health methods for sampling and modelling related to sexual risk behaviour, HIV
and PMTCT. Anna was awareded an honorary
professorship at Hanoi Medical University, Vietnam in 2011. She is a member of
the Global Fund Technical Evaluation Reference Group (TERG).
will focus on the latest evidence-base on sexual transmission of the Zika
virus, and the methodology and rationale
adopted by WHO for making recommendations on the prevention of sexual
transmission of Zika virus.
awarded her PhD in perinatal epidemiology from the University of Oxford in
2014. Prior to that, Colleen received her bachelor degree from Stanford
University and master degree from the Johns Hopkins Bloomberg School of Public
Health. Colleen has extensive experience in research, having been a research
associate at the Stanford University School of Medicine. She was also the
research focal point for the WHO TB and Multidrug resistant TB Programme, WHO
Regional Office for Europe, where she coordinated research capacity building in
Eastern Europe and Central Asia. Colleen additionally served as a field
epidemiologist for the WHO Ebola Response Team in Sierra Leone, and has a long
experience of working in outbreak investigation and early warning surveillance.